Open letter on access to the BIA 10-2474 clinical trial data
Open letter on access to the BIA 10-2474 clinical trial data
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
To the French judicial authorities and to the Executive Director of the European Medicines Agency, In January 2016, the first-in-human (FIH) study of BIA 10-2474, an experimental fatty acid amide hydrolase inhibitor, led to the death of a healthy volunteer and to serious adverse events in another four of the five participants who received the drug...
Alternative Titles
Full title
Open letter on access to the BIA 10-2474 clinical trial data
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1858172139
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1858172139
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(16)32515-6
